A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

A protein found in the saliva of Anopheles gambiae stopped blood from clotting in the insects’ stomachs and aided parasite ...

Results from the malaria vaccine trial indicate that GA2 immunization provides significant protection, paving the way for ...

The discovery of the pGlu-CSP epitope opens up new avenues for developing next-generation malaria vaccines and treatments.

The anti-malarial mAbs evaluated in trials in malaria-endemic regions target the P. falciparum sporozoite-;the life stage of the parasite that is transmitted from mosquitoes to people. By binding ...

The circumsporozoite protein (CSP) has a key role in several stages of the Plasmodium life cycle, including the development of the sporozoite form of the parasite and its entry into the salivary ...

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

NIH researchers identified MAD21-101, a novel antibody targeting a previously unexplored epitope on the malaria parasite.

NIH researchers discover novel class of anti-malaria antibodies: Bethesda, Maryland Monday, January 6, 2025, 16:00 Hrs [IST] A novel class of antibodies that binds to a previously ...